Evaluation and medical management of erectile dysfunction

Thomas J. Beckman, Haitham S. Abu-Lebdeh, Lance A. Mynderse

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

Most men older than 60 years experience some degree of erectile dysfunction (ED). The physiology of erections is complex, with contributions from hormonal, vascular, psychological, neurologic, and cellular components. ED is strongly associated with cardiovascular risk factors, and this fact plays a major role in the prevention and treatment of ED. In this article, we review the evaluation of ED in terms of history, physical examination, and common laboratory studies. Additionally, we review major considerations when prescribing phosphodiesterase type 5 inhibitors and other medical treatments, including intraurethral alprostadil, penile injection therapy, and testosterone replacement.

Original languageEnglish (US)
Pages (from-to)385-390
Number of pages6
JournalMayo Clinic Proceedings
Volume81
Issue number3
DOIs
StatePublished - 2006

Fingerprint

Erectile Dysfunction
Phosphodiesterase 5 Inhibitors
Alprostadil
Nervous System
Physical Examination
Blood Vessels
Testosterone
Therapeutics
History
Psychology
Injections

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Beckman, T. J., Abu-Lebdeh, H. S., & Mynderse, L. A. (2006). Evaluation and medical management of erectile dysfunction. Mayo Clinic Proceedings, 81(3), 385-390. https://doi.org/10.4065/81.3.385

Evaluation and medical management of erectile dysfunction. / Beckman, Thomas J.; Abu-Lebdeh, Haitham S.; Mynderse, Lance A.

In: Mayo Clinic Proceedings, Vol. 81, No. 3, 2006, p. 385-390.

Research output: Contribution to journalReview article

Beckman, TJ, Abu-Lebdeh, HS & Mynderse, LA 2006, 'Evaluation and medical management of erectile dysfunction', Mayo Clinic Proceedings, vol. 81, no. 3, pp. 385-390. https://doi.org/10.4065/81.3.385
Beckman, Thomas J. ; Abu-Lebdeh, Haitham S. ; Mynderse, Lance A. / Evaluation and medical management of erectile dysfunction. In: Mayo Clinic Proceedings. 2006 ; Vol. 81, No. 3. pp. 385-390.
@article{d8bb900c2640427892330896c69b6550,
title = "Evaluation and medical management of erectile dysfunction",
abstract = "Most men older than 60 years experience some degree of erectile dysfunction (ED). The physiology of erections is complex, with contributions from hormonal, vascular, psychological, neurologic, and cellular components. ED is strongly associated with cardiovascular risk factors, and this fact plays a major role in the prevention and treatment of ED. In this article, we review the evaluation of ED in terms of history, physical examination, and common laboratory studies. Additionally, we review major considerations when prescribing phosphodiesterase type 5 inhibitors and other medical treatments, including intraurethral alprostadil, penile injection therapy, and testosterone replacement.",
author = "Beckman, {Thomas J.} and Abu-Lebdeh, {Haitham S.} and Mynderse, {Lance A.}",
year = "2006",
doi = "10.4065/81.3.385",
language = "English (US)",
volume = "81",
pages = "385--390",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "3",

}

TY - JOUR

T1 - Evaluation and medical management of erectile dysfunction

AU - Beckman, Thomas J.

AU - Abu-Lebdeh, Haitham S.

AU - Mynderse, Lance A.

PY - 2006

Y1 - 2006

N2 - Most men older than 60 years experience some degree of erectile dysfunction (ED). The physiology of erections is complex, with contributions from hormonal, vascular, psychological, neurologic, and cellular components. ED is strongly associated with cardiovascular risk factors, and this fact plays a major role in the prevention and treatment of ED. In this article, we review the evaluation of ED in terms of history, physical examination, and common laboratory studies. Additionally, we review major considerations when prescribing phosphodiesterase type 5 inhibitors and other medical treatments, including intraurethral alprostadil, penile injection therapy, and testosterone replacement.

AB - Most men older than 60 years experience some degree of erectile dysfunction (ED). The physiology of erections is complex, with contributions from hormonal, vascular, psychological, neurologic, and cellular components. ED is strongly associated with cardiovascular risk factors, and this fact plays a major role in the prevention and treatment of ED. In this article, we review the evaluation of ED in terms of history, physical examination, and common laboratory studies. Additionally, we review major considerations when prescribing phosphodiesterase type 5 inhibitors and other medical treatments, including intraurethral alprostadil, penile injection therapy, and testosterone replacement.

UR - http://www.scopus.com/inward/record.url?scp=33644694941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644694941&partnerID=8YFLogxK

U2 - 10.4065/81.3.385

DO - 10.4065/81.3.385

M3 - Review article

C2 - 16529142

AN - SCOPUS:33644694941

VL - 81

SP - 385

EP - 390

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 3

ER -